MedPath

Functional Neuroimaging and Genetic Vulnerability to Suicidal Behavior

Not Applicable
Terminated
Conditions
Suicidal Behavior
Interventions
Device: Magnetic resonance imaging (MRI)
Registration Number
NCT02960191
Lead Sponsor
University Hospital, Montpellier
Brief Summary

The main objective is to highlight, by functional imaging (MRI) dysfunctional brain regions associated with vulnerability to suicidal behavior.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Male
Target Recruitment
95
Inclusion Criteria
  • right-handed
  • arm suicidal : Personal history of unipolar depressive disorder or bipolar disorder and having realized in his life at least one suicide attempt
  • arm emotional Witnesses : Personal history of unipolar depressive disorder or bipolar disorder and have never done in his life attempted suicide
  • arm healthy Witnesses : any current or past personal history of psychiatric disorders of Axis I and have never done in his life attempted suicide
Exclusion Criteria
  • Cons-indications to the use of MRI
  • Existence of a past history of head trauma with loss of consciousness or neurological brain disorder or secondary neurological suffering suicidal gesture.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
emotional witnessMagnetic resonance imaging (MRI)subject having had a personal history of unipolar or bipolar depressive disorder and who have never done in his life attempted suicide
patient suicideMagnetic resonance imaging (MRI)subject having had a personal history of unipolar or bipolar depressive disorder and having realized in his life at least one suicide attempt
healthy volunteersMagnetic resonance imaging (MRI)subject with no current or past personal history of psychiatric disorders and about never having carried out suicide attempt
Primary Outcome Measures
NameTimeMethod
MRI variationsat day 0

activation of specific brain areas during the procurement of a test decision

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital of Montpellier

🇫🇷

Montpellier, France

© Copyright 2025. All Rights Reserved by MedPath